|
|
Elizabeth
Garrett-Mayer,
PhD
Director
of Biostatistics
Hollings
Cancer Center
Medical
University of South Carolina
|
My research activities focus on biostatistics in cancer
research. A large fraction of my time is spent collaborating with
oncologists designing and analyzing clinical trials. In designing a
trial, I determine the most efficient way to answer the clinical question of
interest, including how many patients should be studied, and how the trial
will be conducted. The analysis consists of applying statistical
methods to determine if, for example, the new treatment helped patients
survive longer than they would have on another treatment. I also work on
laboratory-based studies, including the exploration of the relationship
between genetic markers and cancer incidence and progression. There are
numerous types of trials and studies within the Cancer Center and so the
analytic methods that I use and the scientific questions I address are quite
varied. My methodologic research relates closely to my applied
interests. My primary statistical research areas of interest are in
early phase studies. Specifically, I work on methods for finding
efficient dose escalation designs and on new trial designs that allow early
stopping when the primary outcome of interest is time to disease progression.
Recent youtube video
about interactions between biostatisticians and basic science
researchers: how NOT to do it!
youtubevideo.com |
Elizabeth Garrett-Mayer, PhD Professor of Biostatistics and Epidemiology |
|
|
|
||
|
|
||
|
Talks from the 2011 Society for
Clinical Trials Meeting for the Invited Session: Frequentist, Bayesian and Likelihood designs
for a Phase II Cancer Trial with a Time-to-Event Endpoint: Head to Head Comparison of Three
Philosophies of Trial Design |
email
me: garrettm@musc.edu